Navigation Links
Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
Date:11/19/2007

ROCKVILLE, Md., Nov. 16 /PRNewswire-USNewswire/ -- For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services. An article based on the report will be posted on-line Monday in the Annals of Internal Medicine.

Researchers reviewed published evidence to compare the benefits and harms of three classes of medications: synthetic disease-modifying antirheumatic drugs (DMARDs), biologic DMARDs and corticosteroids. Synthetic DMARDs include hydroxychloroquine, leflunomide, methotrexate and sulfasalazine; biologic DMARDs include abatacept, adalimumab, anakinra, etanercept, infliximab and rituximab; and corticosteroids include drugs such as prednisone.

The report concluded that combining methotrexate, a synthetic DMARD, with one of the biologic DMARDs works better than using methotrexate or a biologic DMARD alone. The report also found that methotrexate works as effectively as the biologic DMARDs adalimumab and etanercept for patients who have early rheumatoid arthritis. Adalimumab and etanercept, however, show better short-term results as measured by X-rays of joints. The report also emphasized that biologic DMARDs and methotrexate increase the risk of serious infection, including a reoccurrence of tuberculosis.

"Rheumatoid arthritis is a painful, degenerative disease that affects people of all ages and can profoundly impact quality of life," said AHRQ Director Carolyn M. Clancy, M.D. "This report establishes a clear, unbiased summary of what is known about current treatments. It also identifies areas where more research is needed."

About 2 million Americans have rheumatoid arthritis, a long-term illness that causes joint and tissue inflammation. Rheumatoid arthritis is an autoim
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
2. Diet and medications may assist prevention of prostate cancer
3. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
4. Patients cant recall their medications to tell doctors
5. The American Pharmacists Association Supports Consumer Education About OTC Medications
6. For Health Info, Women Often Turn to the Web
7. Doctors Often Miss High Blood Pressure in Kids
8. One Surgery Often Enough for Peritonitis
9. Gene Studies of Male-Female Differences Often Flawed
10. Melanoma Diagnosis Often Delayed for Rural Poor
11. Drinking Often Spurs Move to Poorer Neighborhoods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident Max ... 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, New ... Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto Guzzi ...
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief ... that professional bull rider David Mason has signed an official endorsement deal with the ... age of six and his first bull at 15. He is an Australian bull ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... the cost of graduated compression garments. However, graduated compression garments are an effective ... care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... MO (PRWEB) , ... September 03, 2015 , ... The ... News*, covering the allegations made by IVC filter lawsuits filed against Bard.** ... were harmed when a Bard IVC filter broke or failed, have recently been consolidated ...
(Date:9/3/2015)... (PRWEB) , ... September 03, ... ... Washington, a leading provider of comprehensive eating disorder treatment for adults and ... today that Ileana Calinoiu, MD has joined the medical treatment team. As ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3
... Agreement Would Establish Rules for Union Process, FRESNO, ... delivered a message to CEO Tim Joslin on,Thursday: the ... putting the quality of treatment offered there at risk. ... free and fair election,agreement with employees who are interested ...
... research professionals,from all over the world gathered at the ... Clinical Practice Journal (GCPj) Awards. Opening,this landmark event, Chairman ... said the awards were a most important celebration,of innovation ... hope,it will become a traditional event in the public ...
... Permanente has successfully,certified its greenhouse gas (GHG) emissions ... first health care organization to,earn the distinction of ... voluntarily reporting its 2006 GHG emissions under the,rigorous ... to the organization,s impact on,the environment is another ...
... COLUMBIA, Mo. -- More than 10 million people in the ... are women. For those who could still give birth, cancer ... new $20 million, 5-year program from the National Institutes of ... every aspect of fertility preservation for women with cancer. Part ...
... Pharmaceutical companies,face a unique blend of challenges ... and quality production processes while building,and protecting a ... in the,Multi-Year Compendium of Pharmaceutical Case Studies address ... industry leaders at Global,Benchmarking Council meetings between 2002-2006. ...
... of Military and Veterans Affairs today dedicated a ... and,Sailors, Home., "With the completion of this ... for Pennsylvania,s 1.1 million veterans who,have served so ... Gen.,Jessica L. Wright, state adjutant general. "Now, all ...
Cached Medicine News:Health News:Hospital Workers: Management Threatens Patient Care 2Health News:Good Clinical Practice Journal Awards: Winners Announced 2Health News:Good Clinical Practice Journal Awards: Winners Announced 3Health News:Good Clinical Practice Journal Awards: Winners Announced 4Health News:Kaiser Permanente Achieves Climate Action Leader Status 2Health News:MU researchers to collaborate on $20 million project 2Health News:Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC 2
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
(Date:9/3/2015)... 3, 2015  VirtualScopics, Inc. (NASDAQ: VSCP ... solutions, announced today, they are collaborating with a ... philanthropic, epidemiology study partnering with the Ministry of ... has teamed up with a cardiac sonographer to ... results will be used to identify children with ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) has announced ... Olmesartan Market, 2010-2019" report to their offering. ... by Sankyo Pharmaceuticals Co., Ltd and was patented in ... by FDA to enter the American market in May. ... the world after it succeeded in the US market. ...
Breaking Medicine Technology:Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4China Olmesartan Investigation Market Report 2010-2019 2
... Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development ... oncology, today announced that Dr. Isaac Cohen, O.M.D., Chairman and ... Healthcare Conference at 4:00 p.m. ET on Tuesday, September 28, ... Palace hotel in New York City. Interested parties ...
... Sept. 21 Anthera Pharmaceuticals, Inc. (Nasdaq: ... definitive agreements with certain accredited investors in connection with ... Section 4(2) of the Securities Act of 1933, as ... of the transaction, Anthera will receive gross proceeds of ...
Cached Medicine Technology:Bionovo to Present at the JMP Securities Healthcare Conference 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 3Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 4
... concave seats and large backrests with lumbar ... armrests, and casters and glides. • Choose ... a variety of environments including: industry, education, ... and office. • With tubular base • ...
... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With tubular ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Medicine Products: